George Sverre Robertson - Publications

Affiliations: 
Psychiatry/ Pharmacology Dalhousie University, Halifax, Nova Scotia, Canada 
Area:
neuropharmacology, multiple sclerosis

96 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Nichols M, Zhang J, Polster BM, Elustondo PA, Thirumaran A, Pavlov EV, Robertson GS. Synergistic neuroprotection by epicatechin and quercetin: Activation of convergent mitochondrial signaling pathways. Neuroscience. PMID 26363153 DOI: 10.1016/j.neuroscience.2015.09.012  1
2015 Jie H, Tao S, Liu L, Xia L, Charko A, Yu Z, Bance M, Yin S, Robertson GS, Wang J. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane. Gene Therapy. 22: 546-52. PMID 25809464 DOI: 10.1038/gt.2015.22  1
2014 Ruan Q, Zeng S, Liu A, Chen Z, Yu Z, Zhang R, He J, Bance M, Robertson G, Yin S, Wang J. Overexpression of X-Linked Inhibitor of Apoptotic Protein (XIAP) reduces age-related neuronal degeneration in the mouse cochlea. Gene Therapy. 21: 967-74. PMID 25142138 DOI: 10.1038/gt.2014.77  1
2014 Warford J, Jones QR, Nichols M, Sullivan V, Rupasinghe HP, Robertson GS. The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 268: 71-83. PMID 24485149 DOI: 10.1016/j.jneuroim.2014.01.007  1
2014 Laprairie RB, Warford JR, Hutchings S, Robertson GS, Kelly ME, Denovan-Wright EM. The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients. Journal of Neuroimmunology. 267: 61-72. PMID 24360910 DOI: 10.1016/j.jneuroim.2013.12.008  1
2014 Iorns E, Gunn W, Erath J, Rodriguez A, Zhou J, Benzinou M, Bandrowski A, Booth B, Chaguturu R, Ellis M, Getz G, Haendel M, Ioannidis J, Li JL, Lippman M, ... ... Robertson G, et al. Replication attempt: "Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: Role of leishmanolysin in parasite survival" Plos One. 9. DOI: 10.1371/journal.pone.0114614  1
2013 Squassina A, Manchia M, Chillotti C, Deiana V, Congiu D, Paribello F, Roncada P, Soggiu A, Piras C, Urbani A, Robertson GS, Keddy P, Turecki G, Rouleau GA, Alda M, et al. Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2209-18. PMID 23768751 DOI: 10.1017/S1461145713000655  1
2013 Grant J, Parker K, Moore CS, Keddy PG, Mayne M, Robertson GS. Over-expression of X-linked inhibitor of apoptosis protein modulates multiple aspects of neuronal Ca2+ signaling. Neurochemical Research. 38: 847-56. PMID 23397285 DOI: 10.1007/s11064-013-0989-0  1
2012 Keddy PG, Dunlop K, Warford J, Samson ML, Jones QR, Rupasinghe HP, Robertson GS. Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemic brain injury. Plos One. 7: e51324. PMID 23251498 DOI: 10.1371/journal.pone.0051324  1
2012 Jones QR, Warford J, Rupasinghe HP, Robertson GS. Target-based selection of flavonoids for neurodegenerative disorders. Trends in Pharmacological Sciences. 33: 602-10. PMID 22980637 DOI: 10.1016/j.tips.2012.08.002  1
2012 Wang H, Murphy R, Taaffe D, Yin S, Xia L, Hauswirth WW, Bance M, Robertson GS, Wang J. Efficient cochlear gene transfection in guinea-pigs with adeno-associated viral vectors by partial digestion of round window membrane. Gene Therapy. 19: 255-63. PMID 21697953 DOI: 10.1038/gt.2011.91  1
2012 Robertson GS, Kajitani K. Response to nitric oxide synthase mediation of Darbepoetin's cognitive benefits: A paradoxical effect? Neuropsychopharmacology. 37: 1075. DOI: 10.1038/npp.2011.294  1
2012 Ji X, Rivers L, Zielinski Z, Xu M, MacDougall E, Stephen J, Zhang S, Wang Y, Chapman RG, Keddy P, Robertson GS, Kirby CW, Embleton J, Worrall K, Murphy A, et al. Quantitative analysis of phenolic components and glycoalkaloids from 20 potato clones and in vitro evaluation of antioxidant, cholesterol uptake, and neuroprotective activities Food Chemistry. 133: 1177-1187. DOI: 10.1016/j.foodchem.2011.08.065  1
2011 Warford J, Robertson GS. New methods for multiple sclerosis drug discovery. Expert Opinion On Drug Discovery. 6: 689-99. PMID 22650977 DOI: 10.1517/17460441.2011.573783  1
2011 Crocker CE, Khan S, Cameron MD, Robertson HA, Robertson GS, Lograsso P. JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-hydroxydopamine Model of Parkinson's Disease. Acs Chemical Neuroscience. 2: 207-212. PMID 21666838 DOI: 10.1021/cn1001107  1
2011 Wang J, Tymczyszyn N, Yu Z, Yin S, Bance M, Robertson GS. Overexpression of X-linked inhibitor of apoptosis protein protects against noise-induced hearing loss in mice. Gene Therapy. 18: 560-8. PMID 21228883 DOI: 10.1038/gt.2010.172  1
2010 Hebb AL, Moore CS, Bhan V, Robertson GS. Effects of IFN-B on TRAIL and Decoy Receptor Expression in Different Immune Cell Populations from MS Patients with Distinct Disease Subtypes. Autoimmune Diseases. 2011: 485752. PMID 21253524 DOI: 10.4061/2011/485752  1
2010 Hebb AL, Bhan V, Wishart AD, Moore CS, Robertson GS. Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis. Current Drug Discovery Technologies. 7: 137-40. PMID 20836755  1
2010 Kajitani K, Wafa K, Pasumarthi KB, Robertson GS. Developmental expression of the cyclin D2 splice variant in postnatal Purkinje cells of the mouse cerebellum. Neuroscience Letters. 477: 100-4. PMID 20433897 DOI: 10.1016/j.neulet.2010.04.042  1
2010 Kajitani K, Thorne M, Samson M, Robertson GS. Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1718-28. PMID 20336057 DOI: 10.1038/npp.2010.36  1
2010 Samson ML, Kajitani K, Robertson GS. Nitric-oxide synthase mediates the ability of darbepoetin alfa to attenuate pre-existing spatial working memory deficits in rats subjected to transient global ischemia. The Journal of Pharmacology and Experimental Therapeutics. 333: 437-44. PMID 20167842 DOI: 10.1124/jpet.110.165530  1
2010 Wang J, Menchenton T, Yin S, Yu Z, Bance M, Morris DP, Moore CS, Korneluk RG, Robertson GS. Over-expression of X-linked inhibitor of apoptosis protein slows presbycusis in C57BL/6J mice. Neurobiology of Aging. 31: 1238-49. PMID 18755525 DOI: 10.1016/j.neurobiolaging.2008.07.016  1
2009 Soundararajan R, Sayat R, Robertson GS, Marignani PA. Triptolide: An inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells. Cancer Biology & Therapy. 8: 2054-62. PMID 19783906  1
2009 Thorne M, Moore CS, Robertson GS. Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice. Journal of Neuroimmunology. 211: 92-100. PMID 19428125 DOI: 10.1016/j.jneuroim.2009.04.003  1
2009 Alirezaei M, Fox HS, Flynn CT, Moore CS, Hebb AL, Frausto RF, Bhan V, Kiosses WB, Whitton JL, Robertson GS, Crocker SJ. Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis. Autophagy. 5: 152-8. PMID 19066443 DOI: 10.4161/auto.5.2.7348  1
2009 Robertson GS, LaCasse EC, Holcik M. Programmed Cell Death Pharmacology. 455-473. DOI: 10.1016/B978-0-12-369521-5.00018-X  1
2008 Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE). Journal of Neuroimmunology. 203: 79-93. PMID 18687476 DOI: 10.1016/j.jneuroim.2008.06.030  1
2008 Cowper-Smith CD, Anger GJ, Magal E, Norman MH, Robertson GS. Delayed administration of a potent cyclin dependent kinase and glycogen synthase kinase 3 beta inhibitor produces long-term neuroprotection in a hypoxia-ischemia model of brain injury. Neuroscience. 155: 864-75. PMID 18640243 DOI: 10.1016/j.neuroscience.2008.05.051  1
2008 Hebb AL, Moore CS, Bhan V, Campbell T, Fisk JD, Robertson HA, Thorne M, Lacasse E, Holcik M, Gillard J, Crocker SJ, Robertson GS. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 577-94. PMID 18566024 DOI: 10.1177/1352458507087468  1
2008 Hebb AL, Moore CS, Bhan V, Robertson GS. Targeting apoptosis to treat multiple sclerosis. Current Drug Discovery Technologies. 5: 75-7. PMID 18537570 DOI: 10.2174/157016308783769432  1
2008 Moore CS, Hebb AL, Robertson GS. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes. Journal of Neuroimmunology. 193: 94-105. PMID 18055022 DOI: 10.1016/j.jneuroim.2007.10.022  1
2008 Soundararajan R, Wishart AD, Rupasinghe HP, Arcellana-Panlilio M, Nelson CM, Mayne M, Robertson GS. Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis. The Journal of Biological Chemistry. 283: 2231-45. PMID 18032389 DOI: 10.1074/jbc.M703583200  1
2007 Zehntner SP, Bourbonnière L, Moore CS, Morris SJ, Methot D, St Jean M, Lacasse E, Hebb AL, Robertson GS, Durkin J, Gillard JW, Owens T. X-linked inhibitor of apoptosis regulates T cell effector function. Journal of Immunology (Baltimore, Md. : 1950). 179: 7553-60. PMID 18025200  1
2007 Powell KJ, Hori SE, Leslie R, Andrieux A, Schellinck H, Thorne M, Robertson GS. Cognitive impairments in the STOP null mouse model of schizophrenia. Behavioral Neuroscience. 121: 826-35. PMID 17907815 DOI: 10.1037/0735-7044.121.5.826  1
2006 Wiesner G, Brown RE, Robertson GS, Imran SA, Ur E, Wilkinson M. Increased expression of the adipokine genes resistin and fasting-induced adipose factor in hypoxic/ischaemic mouse brain. Neuroreport. 17: 1195-8. PMID 16837853 DOI: 10.1097/01.wnr.0000224776.12647.ba  1
2006 Robertson GS, Hori SE, Powell KJ. Schizophrenia: an integrative approach to modelling a complex disorder. Journal of Psychiatry & Neuroscience : Jpn. 31: 157-67. PMID 16699601  1
2006 Powell KJ, Binder TL, Hori S, Nakabeppu Y, Weinberger DR, Lipska BK, Robertson GS. Neonatal ventral hippocampal lesions produce an elevation of DeltaFosB-like protein(s) in the rodent neocortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 700-11. PMID 16132062 DOI: 10.1038/sj.npp.1300883  1
2005 Baptiste DC, Powell KJ, Jollimore CA, Hamilton C, LeVatte TL, Archibald ML, Chauhan BC, Robertson GS, Kelly ME. Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience. 134: 575-82. PMID 15939545 DOI: 10.1016/j.neuroscience.2005.04.011  1
2004 Robertson GS, Lee CJ, Sridhar K, Nakabeppu Y, Cheng M, Wang YM, Caron MG. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors. The European Journal of Neuroscience. 20: 3189-94. PMID 15579174 DOI: 10.1111/j.1460-9568.2004.03774.x  1
2004 Ayala-Grosso C, Tam J, Xanthoudakis S, Bureau Y, Roy S, Nicholson DW, Robertson GS. Effects of fimbria-fornix transection on calpain and choline acetyl transferase activities in the septohippocampal pathway. Neuroscience. 126: 927-40. PMID 15207327 DOI: 10.1016/j.neuroscience.2004.04.048  1
2004 Thompson C, Gary D, Mattson M, Mackenzie A, Robertson GS. Kainic acid-induced naip expression in the hippocampus is blocked in mice lacking TNF receptors. Brain Research. Molecular Brain Research. 123: 126-31. PMID 15046874 DOI: 10.1016/j.molbrainres.2004.01.009  1
2004 Toulmond S, Tang K, Bureau Y, Ashdown H, Degen S, O'Donnell R, Tam J, Han Y, Colucci J, Giroux A, Zhu Y, Boucher M, Pikounis B, Xanthoudakis S, Roy S, ... ... Robertson GS, et al. Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease. British Journal of Pharmacology. 141: 689-97. PMID 14744804 DOI: 10.1038/sj.bjp.0705662  1
2003 Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4081-91. PMID 12764095  1
2003 Borisoff JF, Chan CC, Hiebert GW, Oschipok L, Robertson GS, Zamboni R, Steeves JD, Tetzlaff W. Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates. Molecular and Cellular Neurosciences. 22: 405-16. PMID 12691741 DOI: 10.1016/S1044-7431(02)00032-5  1
2003 McPhail LT, Vanderluit JL, McBride CB, Oschipok LW, Crocker SJ, Xu D, Thompson CS, Liston P, Holcik M, Robertson GS, Tetzlaff W. Endogenous expression of inhibitor of apoptosis proteins in facial motoneurons of neonatal and adult rats following axotomy. Neuroscience. 117: 567-75. PMID 12617963 DOI: 10.1016/S0306-4522(02)00742-X  1
2002 Ayala-Grosso C, Ng G, Roy S, Robertson GS. Caspase-cleaved amyloid precursor protein in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 12: 430-41. PMID 12408229  1
2002 Hu XT, Koeltzow TE, Cooper DC, Robertson GS, White FJ, Vezina P. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens. Synapse (New York, N.Y.). 45: 159-70. PMID 12112395 DOI: 10.1002/syn.10095  1
2002 Han BH, Xu D, Choi J, Han Y, Xanthoudakis S, Roy S, Tam J, Vaillancourt J, Colucci J, Siman R, Giroux A, Robertson GS, Zamboni R, Nicholson DW, Holtzman DM. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. The Journal of Biological Chemistry. 277: 30128-36. PMID 12058036 DOI: 10.1074/jbc.M202931200  1
2002 Davoli MA, Ren Y, Zhu Y, Fourtounis J, Jones C, Robertson GS, Ng GY, Xu D. Automated analysis of global ischemia-induced CA1 neuronal death using terminal UTP nick end labeling (TUNEL). Journal of Neuroscience Methods. 115: 55-61. PMID 11897363 DOI: 10.1016/S0165-0270(01)00531-3  1
2001 Hutchison JS, Derrane RE, Johnston DL, Gendron N, Barnes D, Fliss H, King WJ, Rasquinha I, MacManus J, Robertson GS, MacKenzie AE. Neuronal apoptosis inhibitory protein expression after traumatic brain injury in the mouse. Journal of Neurotrauma. 18: 1333-47. PMID 11780864 DOI: 10.1089/08977150152725632  1
2001 Lamontagne S, Meadows E, Luk P, Normandin D, Muise E, Boulet L, Pon DJ, Robichaud A, Robertson GS, Metters KM, Nantel F. Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey. Brain Research. 920: 84-96. PMID 11716814 DOI: 10.1016/S0006-8993(01)03023-2  1
2001 Crocker SJ, Wigle N, Liston P, Thompson CS, Lee CJ, Xu D, Roy S, Nicholson DW, Park DS, MacKenzie A, Korneluk RG, Robertson GS. NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease. The European Journal of Neuroscience. 14: 391-400. PMID 11553289 DOI: 10.1046/j.0953-816X.2001.01653.x  1
2001 Simpson MT, MacLaurin JG, Xu D, Ferguson KL, Vanderluit JL, Davoli MA, Roy S, Nicholson DW, Robertson GS, Park DS, Slack RS. Caspase 3 deficiency rescues peripheral nervous system defect in retinoblastoma nullizygous mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 7089-98. PMID 11549719  1
2000 Calon F, Hadj Tahar A, Blanchet PJ, Morissette M, Grondin R, Goulet M, Doucet JP, Robertson GS, Nestler E, Di Paolo T, Bédard PJ. Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends in Neurosciences. 23: S92-100. PMID 11052226  1
2000 Vanderluit JL, McPhail LT, Fernandes KJ, McBride CB, Huguenot C, Roy S, Robertson GS, Nicholson DW, Tetzlaff W. Caspase-3 is activated following axotomy of neonatal facial motoneurons and caspase-3 gene deletion delays axotomy-induced cell death in rodents. The European Journal of Neuroscience. 12: 3469-80. PMID 11029616 DOI: 10.1046/j.1460-9568.2000.00241.x  1
2000 Keramaris E, Stefanis L, MacLaurin J, Harada N, Takaku K, Ishikawa T, Taketo MM, Robertson GS, Nicholson DW, Slack RS, Park DS. Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage. Molecular and Cellular Neurosciences. 15: 368-79. PMID 10845773 DOI: 10.1006/mcne.2000.0838  1
2000 Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS, Park DS. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. The Journal of Biological Chemistry. 275: 11553-60. PMID 10766769 DOI: 10.1074/jbc.275.16.11553  1
2000 Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. Neuroprotection by the inhibition of apoptosis. Brain Pathology (Zurich, Switzerland). 10: 283-92. PMID 10764048  1
1999 Bédard PJ, Blanchet PJ, Lévesque D, Soghomonian JJ, Grondin R, Morissette M, Goulet M, Calon F, Falardeau P, Gomez-Mancilla B, Doucet JP, Robertson GS, DiPaolo T. Pathophysiology of L-dopa-induced dyskinesias. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 4-8. PMID 10493397  1
1999 Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS, Slack RS. Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 7860-9. PMID 10479688  1
1999 Xu D, Bureau Y, McIntyre DC, Nicholson DW, Liston P, Zhu Y, Fong WG, Crocker SJ, Korneluk RG, Robertson GS. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5026-33. PMID 10366635  1
1998 Tu Y, Hou ST, Huang Z, Robertson GS, MacManus JP. Increased Mdm2 expression in rat brain after transient middle cerebral artery occlusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 658-69. PMID 9626190 DOI: 10.1097/00004647-199806000-00008  1
1998 McGahan L, Hakim AM, Nakabeppu Y, Robertson GS. Ischemia-induced CA1 neuronal death is preceded by elevated FosB and Jun expression and reduced NGFI-A and JunB levels. Brain Research. Molecular Brain Research. 56: 146-61. PMID 9602101 DOI: 10.1016/S0169-328X(98)00039-4  1
1998 Hazell AS, McGahan L, Tetzlaff W, Bedard AM, Robertson GS, Nakabeppu Y, Hakim AM. Immediate-early gene expression in the brain of the thiamine-deficient rat. Journal of Molecular Neuroscience : Mn. 10: 1-15. PMID 9589366 DOI: 10.1007/BF02737081  1
1998 Crocker SJ, Morelli M, Wigle N, Nakabeppu Y, Robertson GS. D1-Receptor-related priming is attenuated by antisense-meditated 'knockdown' of fosB expression. Brain Research. Molecular Brain Research. 53: 69-77. PMID 9473593 DOI: 10.1016/S0169-328X(97)00281-7  1
1997 Hou ST, Tu Y, Buchan AM, Huang Z, Preston E, Rasquinha I, Robertson GS, MacManus JP. Increases in DNA lesions and the DNA damage indicator Gadd45 following transient cerebral ischemia. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 75: 383-92. PMID 9493961  1
1997 Budzikowski AS, Vahid-Ansari F, Robertson GS, Leenen FH. Patterns of neuronal activation during development of sodium sensitive hypertension in SHR. Hypertension. 30: 1572-7. PMID 9403585  1
1997 Gramolini AO, Dennis CL, Tinsley JM, Robertson GS, Cartaud J, Davies KE, Jasmin BJ. Local transcriptional control of utrophin expression at the neuromuscular synapse. The Journal of Biological Chemistry. 272: 8117-20. PMID 9079621 DOI: 10.1074/jbc.272.13.8117  1
1996 Vahid-Ansari F, Robertson GS. 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain. The European Journal of Neuroscience. 8: 2605-11. PMID 8996810 DOI: 10.1111/j.1460-9568.1996.tb01555.x  1
1996 Robertson GS, Fibiger HC. Effects of olanzapine on regional C-Fos expression in rat forebrain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 105-110. PMID 8822533 DOI: 10.1016/0893-133X(95)00196-K  1
1995 Robertson GS, Jian M. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience. 64: 1019-34. PMID 7753373 DOI: 10.1016/0306-4522(94)00426-6  1
1995 Robertson GS, Tetzlaff W, Bedard A, St-Jean M, Wigle N. C-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum. Neuroscience. 67: 325-44. PMID 7675173 DOI: 10.1016/0306-4522(95)00049-O  1
1994 Robertson GS, Matsumura H, Fibiger HC. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. The Journal of Pharmacology and Experimental Therapeutics. 271: 1058-66. PMID 7965768  1
1994 Robertson GS, Staines WA. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y. Neuroscience. 59: 375-87. PMID 7911982 DOI: 10.1016/0306-4522(94)90603-3  1
1993 Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. The Journal of Pharmacology and Experimental Therapeutics. 264: 1344-51. PMID 8095550  1
1993 Jian M, Staines WA, Iadarola MJ, Robertson GS. Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons. Brain Research. Molecular Brain Research. 19: 156-60. PMID 7689681 DOI: 10.1016/0169-328X(93)90161-H  1
1993 Fibiger HC, Robertson GS, Guo N. How do atypical antipsychotics work - clues from c-fos studies European Neuropsychopharmacology. 3: 236-237. DOI: 10.1016/0924-977X(93)90047-P  1
1992 Robertson GS, Vincent SR, Fibiger HC. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49: 285-96. PMID 1359451 DOI: 10.1016/0306-4522(92)90096-K  1
1992 Robertson GS, Hubert GW, Tham CS, Fibiger HC. Lesions of the mesotelencephalic dopamine system enhance the effects of selective dopamine D1 and D2 receptor agonists on striatal acetylcholine release. European Journal of Pharmacology. 219: 323-5. PMID 1358643 DOI: 10.1016/0014-2999(92)90313-S  1
1992 Robertson GS, Fibiger HC. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46: 315-28. PMID 1347406 DOI: 10.1016/0306-4522(92)90054-6  1
1991 Damsma G, Robertson GS, Tham CS, Fibiger HC. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. The Journal of Pharmacology and Experimental Therapeutics. 259: 1064-72. PMID 1837058  1
1991 Robertson GS, Pfaus JG, Atkinson LJ, Matsumura H, Phillips AG, Fibiger HC. Sexual behavior increases c-fos expression in the forebrain of the male rat. Brain Research. 564: 352-7. PMID 1810635 DOI: 10.1016/0006-8993(91)91477-I  1
1991 Robertson GS, Damsma G, Fibiger HC. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 2209-16. PMID 1712381  1
1991 Robertson GS, Fine A, Robertson HA. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats. Brain Research. 539: 304-11. PMID 1675908 DOI: 10.1016/0006-8993(91)91634-D  1
1990 Robertson GS, Vincent SR, Fibiger HC. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Research. 523: 288-90. PMID 2144781 DOI: 10.1016/0006-8993(90)91498-6  1
1990 Damsma G, Tham CS, Robertson GS, Fibiger HC. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. European Journal of Pharmacology. 186: 335-8. PMID 1981190 DOI: 10.1016/0014-2999(90)90456-G  1
1990 Dragunow M, Robertson GS, Faull RL, Robertson HA, Jansen K. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience. 37: 287-94. PMID 1966822 DOI: 10.1016/0306-4522(90)90399-O  1
1989 Robertson GS, Robertson HA. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 3326-31. PMID 2795165  1
1989 Robertson HA, Peterson MR, Murphy K, Robertson GS. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Research. 503: 346-9. PMID 2532558 DOI: 10.1016/0006-8993(89)91689-2  1
1989 Robertson GS, Herrera DG, Dragunow M, Robertson HA. L-dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. European Journal of Pharmacology. 159: 99-100. PMID 2495972 DOI: 10.1016/0014-2999(89)90049-6  1
1988 Robertson GS, Robertson HA. Evidence that the substantia nigra is a site of action for L-DOPA. Neuroscience Letters. 89: 204-8. PMID 3393296 DOI: 10.1016/0304-3940(88)90382-5  1
1988 Dragunow M, Robertson HA, Robertson GS. Amygdala kindling and c-fos protein(s). Experimental Neurology. 102: 261-3. PMID 3141205 DOI: 10.1016/0014-4886(88)90103-3  1
1987 Robertson HA, Robertson GS. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action. Clinical Neuropharmacology. 10: 384-7. PMID 3503682  1
1987 Robertson GS, Robertson HA. D1 and D2 dopamine agonist synergism: separate sites of action? Trends in Pharmacological Sciences. 8: 295-299. DOI: 10.1016/0165-6147(87)90121-0  1
1986 Robertson GS, Robertson HA. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats. Brain Research. 384: 387-90. PMID 2946360 DOI: 10.1016/0006-8993(86)91178-9  1
1986 Robertson HA, Robertson GS. The antiparkinson action of bromocriptine in combination with levodopa Trends in Pharmacological Sciences. 7: 224-225. DOI: 10.1016/0165-6147(86)90325-1  1
Show low-probability matches.